CD8A and hepatocellular carcinoma: revealed that enhanced expression of CD39 on TAMs, which is induced by HCC-secreted exosomal circTMEM181, could collaborate with CD73 to fulfill the sequential activation of the ATP–adenosine pathway, impair CD8+ T-cell function, and build a PD-1 antibody-resistant tumor environment (71).